Drug Profile
Research programme: diabetes therapy - Digital Gene Technologies
Alternative Names: diabetes therapy research programme - Digital Gene Technologies; Research programme: gene discovery - Digital Gene TechnologiesLatest Information Update: 22 Sep 2006
Price :
$50
*
At a glance
- Originator Digital Gene Technologies; Harvard Medical School
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 08 Feb 2001 Collaboration between DGT and the Mayo Medical Centre to investigate the role of the ER81 transcription factor in breast and ovarian cancer
- 05 Feb 2001 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)